Duo-medihaler side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Duo-medihaler. Common side effects include erythema among females.
The phase IV clinical study is created by eHealthMe based on 1 report from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
What are phase IV trials?
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1 person who takes Duo-Medihaler and has side effects is studied.
What is Duo-Medihaler?
Duo-medihaler has active ingredients of isoproterenol hydrochloride; phenylephrine bitartrate. Currently, eHealthMe is studying from 1 Duo-medihaler user.
Number of Duo-medihaler reports submitted per year:
Duo-Medihaler side effects by gender *:
female:
- Erythema (redness of the skin)
male:
n/a
Duo-Medihaler side effects by age (0-1 to 60+) *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Erythema (redness of the skin)
* Approximation only. Some reports may have incomplete information.
Do you take Duo-medihaler?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on isoproterenol hydrochloride; phenylephrine bitartrate (the active ingredients of Duo-medihaler) and Duo-medihaler (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Duo-medihaler:
- Duo-medihaler (1 reports)
All Duo-medihaler side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Entacapone and Gastric Ulcer - 9 seconds ago
- Pantoprazole Sodium and Mean Cell Haemoglobin Decreased - 13 seconds ago
- Ramipril and Coronary Artery Disease Aggravated - 15 seconds ago
- Breo Ellipta and Tendon Injury - 15 seconds ago
- Mupirocin and Gastritis Aggravated - 17 seconds ago
- Brilinta and Sneezing - 27 seconds ago
- Zenapax and Rocephin drug interaction - 30 seconds ago
- Polycythemia Vera and drugs of ingredients of meloxicam - 35 seconds ago
- Amlodipine Besylate and Ulcerative Colitis - 36 seconds ago
- Cefuroxime and Azathioprine drug interaction - 39 seconds ago